Evidence map›Paper›PMID 41594631›Full record

ReviewBiomolecules2026

Intrinsic Asymmetry in Weak Acid Transmembrane Transporters.

Emmi Jaeger, Sebastian Buss, Eric Beitz

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emmi JaegerPharmaceutical Institute, Kiel University, Gutenbergstr. 76, 24118 Kiel, Germany.
Sebastian BussPharmaceutical Institute, Kiel University, Gutenbergstr. 76, 24118 Kiel, Germany.ORCID 0009-0008-1942-1741
Eric BeitzPharmaceutical Institute, Kiel University, Gutenbergstr. 76, 24118 Kiel, Germany.ORCID 0000-0001-5912-6626

Funding

Deutsche Forschungsgemeinschaft Be2253/8Dr. Hilmer Stifung T 0146 - 42.804European Commission 101227436European Commission 860592
6 · The paper itself

Abstract

Transmembrane facilitation of substrates by channels and secondary active transporters results in a defined steady-state concentration ratio across the membrane. Evidence is accumulating that asymmetry in the structural build of the transporters, or interaction with asymmetric partner proteins, can shift the position of the transmembrane equilibrium by biased transport directionality. For instance, the bacterial lactose transporter, LacY, and two amino acid transporters, i.e., the human excitatory amino acid carrier, EAAC1, and the yeast lysine permease, Lyp1, were reported to exhibit distinct transport kinetics in the inward and outward direction by protein-intrinsic properties. A recent example is transport modulation of human monocarboxylate transporters, MCT, by shedding of the extracellular domain of an ancillary protein, basigin. Loss of the domain selectively increases export of lactate from lung cancer cells by a factor of four, contributing to the Warburg effect and malignancy. Further, intrinsic properties of monocarboxylate transporters involving asymmetric affinities of substrate binding, or biased open probabilities were shown to generate preference for one transport direction. Here, we discuss molecular mechanisms and physiological contexts of asymmetric secondary active transmembrane transport. Focus is laid on experimentally established cases, and examples are given in which putative bias in transport directionality may have been overlooked.

Indexed as

Membrane Transport ProteinsMonocarboxylic Acid TransportersAnimalsBasiginBiological TransportHumansBasiginMembrane Transport ProteinsMonocarboxylic Acid Transportersaquaporinasymmetrybasiginchannelfacilitatorlactatemonocarboxylateprotontransmembrane transportWarburg effect

Identifiers

PMID41594631
PMCPMC12838822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.